BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 1, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 4, 2004
View Archived Issues
Gilead's Combination HIV Drug, Truvada, Wins FDA Clearance
The FDA granted accelerated approval for Truvada, a fixed-dose combination of Gilead Sciences Inc.'s anti-HIV medications Emtriva and Viread. (BioWorld Today)
Read More
FDA Examining BLAs To Counter Smallpox Vaccine's Side Effects
Read More
Micrologix Signs Up Another Partner For Catheter Therapy
Read More
Elusys Raises $10.2M Via Series D Financing Round
Read More
Other News To Note
Read More